Learn More
Invitrogen™ Equine TNF-alpha Recombinant Protein
Description
For dilution, use a buffer containing carrier protein, e.g. PBS with 1% BSA or a neutral media containing 10% FCS and freeze in aliquots at -70°C. Activity: The biological activity of recombinant equine TNFa was measured by its cytolytic effect on mouse WEHI-13VAR cells in the presence of Actinomycin D. Expression: The mature, soluble form of equine TNF-alpha was expressed in Pichia pastoris, KM71H. GenBank™ Accession # P29553, amino acids 78-234. Reconstitute with 0.5 mL of distilled water.

Specifications
Specifications
Accession Number | P29553 |
For Use With (Application) | ELISA, Immunoprecipitation, Western Blot |
Formulation | PBS with no preservative |
Gene ID (Entrez) | 100033834 |
Molecular Weight (g/mol) | 17.1 kDa |
Name | Equine TNF-alpha |
Quantity | 20 μg |
Source | Yeast |
Regulatory Status | RUO |
Gene Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF a; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFa; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1 F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
Show More |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.